Hyperthyroidism: A Review

Overt hyperthyroidism, defined as suppressed thyrotropin (previously thyroid-stimulating hormone) and high concentration of triiodothyronine (T3) and/or free thyroxine (FT4), affects approximately 0.2% to 1.4% of people worldwide. Subclinical hyperthyroidism, defined as low concentrations of thyrotr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2023-10, Vol.330 (15), p.1472-1483
Hauptverfasser:	Lee, Sun Y, Pearce, Elizabeth N
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Adult Antibodies Antithyroid Agents - therapeutic use Cardiovascular diseases Congestive heart failure Diarrhea Drugs Dysphagia Etiology Female Graves disease Graves Disease - complications Graves Disease - diagnosis Graves Disease - therapy Health risks Health services Heart diseases Humans Hyperthyroidism Hyperthyroidism - diagnosis Hyperthyroidism - epidemiology Hyperthyroidism - etiology Hyperthyroidism - therapy Insomnia Iodine Iodine - therapeutic use Iodine radioisotopes Iodine Radioisotopes - therapeutic use Low concentrations Male Mortality Nodules Osteoporosis Osteoporosis - etiology Patients Pregnancy Scintigraphy Signs and symptoms Sleep disorders Surgery Thyroid Thyroid gland Thyroid hormones Thyroid Neoplasms - complications Thyroid Nodule - complications Thyroid-stimulating hormone Thyroiditis Thyroiditis - complications Thyrotoxicosis Thyrotoxicosis - diagnosis Thyrotoxicosis - etiology Thyrotoxicosis - therapy Thyrotropin - analysis Thyroxine Thyroxine - therapeutic use Triiodothyronine Weight Loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!